XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Moderna Collaboration and License Agreement - Narratives (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 30 Months Ended
Jul. 03, 2024
USD ($)
Jun. 30, 2024
USD ($)
Jan. 31, 2022
USD ($)
product
target
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
obligation
target
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Moderna Collaboration and License Agreement                    
Collaboration revenues       $ 9,200 $ 3,600 $ 12,600 $ 6,800      
Deferred revenue liability   $ 41,909   41,909 46,416 41,909 46,416 $ 41,909 $ 46,413 $ 47,459
Collaboration revenues       9,197 $ 3,560 12,594 $ 6,803      
Option Right Collaboration Revenues                    
Moderna Collaboration and License Agreement                    
Collaboration revenues       3,800   3,800        
Milestones                    
Moderna Collaboration and License Agreement                    
Collaboration revenues       2,000   $ 2,000        
Collaboration and License Agreement                    
Moderna Collaboration and License Agreement                    
Number of potential research target designations | target           12        
Collaboration and License Agreement | Research and Development Services                    
Moderna Collaboration and License Agreement                    
Variable consideration           $ 73,900        
Term of contract           5 years        
Noncurrent portion of deferred revenue   41,300   41,300   $ 41,300   41,300    
Collaboration and License Agreement | Moderna                    
Moderna Collaboration and License Agreement                    
Maximum of research targets | target     12              
Number of research targets, designate as development targets | target     12              
Number of research targets designated | target     5              
Collaboration and License Agreement | Moderna | Research and Development Services                    
Moderna Collaboration and License Agreement                    
Upfront non-refundable payment received     $ 45,000     $ 45,000        
Number of potential products to develop and commercialize | product     12              
Minimum commitment to reimburse research and development costs     $ 10,000              
Period of reimbursement of research and development costs     3 years              
Number of performance obligations | obligation           2        
Collaboration and License Agreement | Moderna | Minimum | Research and Development Services                    
Moderna Collaboration and License Agreement                    
Amount receivable per product     $ 247,000              
Collaboration and License Agreement | Moderna | Maximum | Research and Development Services                    
Moderna Collaboration and License Agreement                    
Amount receivable per product     $ 253,000              
Moderna License Agreement | Research and Development Services                    
Moderna Collaboration and License Agreement                    
Collaboration revenues               31,600    
Moderna License Agreement | Option Right Collaboration Revenues                    
Moderna Collaboration and License Agreement                    
Collaboration revenues               3,800    
Moderna License Agreement | Moderna                    
Moderna Collaboration and License Agreement                    
Milestone payment   2,000   2,000   $ 2,000   2,000    
Collaboration revenues   2,000                
Deferred revenue liability   $ 45,000   $ 45,000   45,000   $ 45,000    
Decrease in contract with customer, liability           $ 3,800        
Moderna License Agreement | Moderna | Subsequent Event                    
Moderna Collaboration and License Agreement                    
Proceeds related to collaboration revenue $ 2,000